Sintx Technologies enters its May 20 earnings call in an unusual position — short sellers have been exiting rapidly while company insiders have been buying at every dip, creating a quiet divergence that deserves attention ahead of the print.
The short-side retreat is the clearest recent story. SI % of FF has dropped from a peak near 12% in mid-April to 3.6% — a fall of 40% over the past month, and 15% in the last week alone. The formal FINRA count, settled April 30, still shows 222,373 shares short with a 6.4 days-to-cover, but the daily estimate suggests those positions have been cut sharply since. Cost to borrow has drifted down roughly 11% over the week to 15.7%, though it remains meaningfully elevated compared to early April levels near 10–12% — a reminder that the borrow market still treats SINT as a high-friction name. Availability has eased notably: the lending pool was almost entirely spoken for in late April and early May, when utilisation briefly hit 95.8%, but it has since loosened back to roughly 70%. The borrow market has relaxed, but it is not loose.
Where short sellers have been stepping back, insiders have been stepping in. The company has logged net purchases of roughly 17,200 shares worth about $50,000 in the 90 days through mid-April — a modest dollar figure, but meaningful in context for a micro-cap stock at these price levels. A President-level buy at $2.89 on April 13 followed earlier purchases by directors at prices between $2.91 and $3.02 in February and March. Executive Director Gregg Honigblum — the single largest individual holder with just over 4.9% of shares — added aggressively in December at prices between $3.94 and $4.28. Every one of those transactions was done below current book value. The pattern is one of consistent accumulation, not a one-off vote of confidence.
The analyst picture is supportive on paper, but the gap between Street targets and the current price demands a caveat. HC Wainwright initiated with a Buy and a $10 target on April 13 — the freshest piece of coverage — while Ascendiant Capital has maintained its Buy rating through a succession of target cuts, most recently to $12 from $16 in early April. The consensus mean stands near $10.17, against a current price of $2.27. That gap is large enough to flag as potentially stale relative to the stock's structural evolution; the targets should be treated as directional signals rather than precise anchors. What they do confirm is that the two firms covering the name remain constructive and neither has moved to the sidelines.
The broader positioning backdrop is cautious. SINT's ORTEX short score of 64.7 puts it in the bottom decile on short-score rank — meaning short-related pressure is elevated relative to peers even as the headline SI number has fallen. Factor scores elsewhere are sparse for this micro-cap name; the stock carries no dividend and its valuation multiples are all negative (the company is pre-profit), making conventional valuation comparisons uninformative. Price action has been weak: down 19% over the past month to $2.27, with a 5.6% slide on the latest session alone. Closest correlated peer GCTK fell nearly 19% on the week, while HSDT managed a 3.6% gain — the peer group is fragmented, with no clean directional read.
The May 20 earnings release is the next pivot point. SINT's two previous prints both produced same-day declines of 1.2% and 4.5% respectively, though the five-day reaction after November 2025's print was a positive 23.5%, suggesting delayed recoveries are possible when the results are not materially negative. With shorts having already reduced exposure, the residual squeeze dynamic is less of a factor than it was in April; the release will be judged primarily on progress against commercial milestones in the silicon nitride ceramics platform, and whether the cash position has held up against the burn rate the bears continue to flag.
See the live data behind this article on ORTEX.
Open SINT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
